CRYPTO$ATOM
Cosmos · Q1 2025 earnings
Q1 2025 earnings · · After market close
Briefing
Atomera reported Q1 2025, revenue of $4K, net loss of $5.2M, diluted EPS of $-0.17.
For Q1 2025, Atomera reported revenue of $4K, a net loss of $5.2M, diluted EPS was $-0.17. Management discusses operating trends, capital, and sector risks in the quarterly filing.
- Q1 2025 revenue $4K.
- Net loss $5.2M.
- Diluted EPS $-0.17.
Headline financials
Revenue & EPS history
Cosmos · Revenue · Quarterly
$4K
Forward guidance
Biotech filers emphasize pipeline milestones, regulatory events, and cash runway; GAAP earnings can be dominated by collaboration or one-time items.
Tailwinds
- Commercial product ramps where approved.
- Partnership funding and milestone payments.
- Pipeline catalysts in cardiovascular and rare disease.
Headwinds
- Trial or regulatory setback risk.
- R&D spend ahead of revenue for pre-commercial assets.
- Exclusivity cliffs and reimbursement pressure.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2025
+0.5%
Avg return
Earnings day
+4.1%
Avg return
5 days after
+1.5%
Avg return
30 days after
49%
19 / 39 earnings
Positive
+64.0%
Q4 2025
Best reaction
-38.5%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.7% | -21.6% | -84.2% | |
| Q4 2025 | +64.0% | +129.3% | +92.5% | |
| Q3 2025 | +3.0% | -11.7% | -23.7% | |
| Q1 2025 | +2.2% | +36.5% | +22.9% | |
| Q4 2024 | -38.5% | -29.4% | -31.8% | |
| Q3 2024 | +15.7% | +21.4% | +58.3% | |
| Q2 2024 | +10.4% | -3.1% | -14.2% | |
| Q1 2024 | -21.9% | -18.6% | -26.0% | |
| Q4 2023 | -21.6% | -22.2% | -33.1% | |
| Q3 2023 | -7.0% | -17.0% | +14.1% | |
| Q2 2023 | -14.5% | -10.5% | -26.1% | |
| Q1 2023 | +32.8% | +55.9% | +89.8% | |
| Q4 2022 | -18.1% | -16.9% | -18.6% | |
| Q3 2022 | -5.1% | -3.9% | -25.5% | |
| Q2 2022 | +13.8% | +23.4% | +7.5% | |
| Q1 2022 | +15.3% | +16.8% | +32.8% | |
| Q4 2021 | +12.8% | +6.3% | -18.7% | |
| Q3 2021 | -0.4% | +2.8% | +6.6% | |
| Q2 2021 | +21.8% | +36.0% | +43.6% | |
| Q1 2021 | -22.4% | -24.8% | -18.3% | |
| Q4 2020 | -17.9% | -12.0% | -39.0% | |
| Q3 2020 | -6.2% | -0.6% | +7.1% | |
| Q2 2020 | +8.8% | +5.5% | -12.7% | |
| Q1 2020 | -9.2% | -7.3% | +50.7% | |
| Q4 2019 | -13.6% | -16.4% | -44.4% | |
| Q3 2019 | -11.3% | -9.5% | -19.7% | |
| Q2 2019 | -11.9% | -13.7% | -25.0% | |
| Q1 2019 | +3.8% | +46.2% | +62.3% | |
| Q4 2018 | +6.2% | +3.8% | -7.8% | |
| Q3 2018 | -1.0% | -3.4% | -12.2% | |
| Q2 2018 | -2.2% | -5.2% | -15.5% | |
| Q1 2018 | +20.2% | +13.5% | +18.3% | |
| Q4 2017 | -0.6% | +7.6% | +33.5% | |
| Q3 2017 | +4.8% | +6.7% | +50.6% | |
| Q2 2017 | -7.7% | -10.4% | -7.3% | |
| Q1 2017 | +1.1% | -0.2% | -29.0% | |
| Q4 2016 | +5.9% | +6.4% | +8.2% | |
| Q3 2016 | -2.2% | -3.6% | -1.5% | |
| Q2 2016 | +7.8% | +2.0% | -5.2% | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro